Cover image for HIV
Libman, Howard.
Publication Information:
Philadelphia : American College of Physicians, [2003]

Physical Description:
xi, 356 pages, 2 unnumbered pages of color plates : illustrations ; 23 cm.
Format :


Call Number
Material Type
Home Location
Item Holds
RC606.63 .H55 2003 Adult Non-Fiction Central Closed Stacks

On Order



This edition of the successful HIV is fully revised and updated. It includes new information on antiretroviral therapy, long term treatment complications, resistance testing and therapeutic drug monitoring, diagnosis and management of opportunistic infections and cancers, prevention of opportunistic infections, diagnostic approach to common clinical syndromes, and HIV infection in special populations.

Reviews 1

Choice Review

The care of HIV-infected patients has evolved dramatically over the past several years. What was previously a progressive disease manifested by opportunistic infections and neoplasms is now a treatable chronic medical condition in many patients. However, the significant changes in management that prompted this transformation, including combination antiretroviral therapy, viral load measurement, and resistance testing, have resulted in important challenges for clinicians. Drug resistance and long-term treatment complications have become common concerns. This second edition of HIV (1st ed., CH, Oct'00), the initial volume of the American College of Physicians' new "Therapy" series, provides the latest essential information for the primary care of HIV-infected patients. All chapters, written by a team of authors with established clinical, teaching, and research expertise, have been thoroughly updated to incorporate the latest research into clinical practice. Unique to this edition are new chapters that address drug-resistance testing, long-term treatment complications, and HIV in special populations (women, minorities, injection-drug users). An effort has been made to present a reasonable approach to management based on recent medical literature and accepted standards of clinical practice. A valuable resource for anyone interested in the medical aspects of HIV disease. ^BSumming Up: Recommended. Upper-division undergraduates through professionals. J. M. Howe Veterans Administration

Table of Contents

Kenneth H. MayerSigall K. BellSigall K. BellHarvey J. Makadon and Steven A. SafrenHoward Libman and Jon D. FullerMarissa B. Wilck and Paul E. SaxEdward P. Acosta and John G. Gerber and Daniel R. KuritzkesPatrick W.G. Mallon and David A. Cooper and Andrew CarrMatthew R. Leibowitz and Judith S. CurrierAmita Gupta and Lisa R. Hirschhorn and Peter J. Piliero and Joel E. GallantSonia Nagy Chimienti and Lori A. Panther and Camilla S. GrahamBruce J. DezubeJohn P. DoweikoJohn P. DoweikoRaymond O. Powrie and Susan Cu-UvinBenjamin DavisEric P. GoosbyGregory FentonJeffrey H. SametMichael T. Wong and Sonia Nagy ChimientiMegan O'Brien and Elizabeth A. McCarthyLisa A. CosimiWilliam RodriguezLouise IversHoward LibmanVictoria A. Johnson and Francoise Brun-Vezinet and Bonaventura Clotet and Daniel R. Kuritzkes and Deenan Pillay and Jonathan M. Schapiro and Douglas D. Richman
Prefacep. ix
Chapter 1 Transmission, Pathogenesis, and Natural Historyp. 1
I Transmissionp. 2
II Pathogenesisp. 17
III Natural Historyp. 25
Chapter 2 Prevention of HIV Infectionp. 35
Chapter 3 Primary Care of HIV Infectionp. 47
Chapter 4 Antiretroviral Therapyp. 75
Chapter 5 Antiretroviral Pharmacokinetics, Resistance Testing, and Therapeutic Drug Monitoringp. 115
Chapter 6 Long-Term Treatment Complicationsp. 137
Chapter 7 Prevention of Opportunistic Infectionsp. 163
Chapter 8 Diagnostic Approach to Common Clinical Syndromesp. 177
Chapter 9 Diagnosis and Management of Opportunistic Infectionsp. 209
Chapter 10 Diagnosis and Management of Opportunistic Cancersp. 271
I Kaposi's Sarcomap. 271
II HIV-Related Lymphomasp. 282
III Anogenital Squamous Cell Cancerp. 292
Chapter 11 HIV Infection in Special Populationsp. 295
I Womenp. 295
II Men Who Have Sex with Menp. 304
III African Americansp. 309
IV Transgender Personsp. 313
V Injection-Drug Usersp. 317
Chapter 12 Antiretroviral Post-Exposure Prophylaxisp. 325
Chapter 13 HIV Global Epidemiologyp. 345
Chapter 14 Clinical Considerations in Developing Countriesp. 361
Chapter 15 Antiretroviral Treatment in Resource-Limited Settingsp. 369
Chapter 16 Barriers to Implementing Care in Resource-Limited Settingsp. 385
Appendix I HIV Drug Glossaryp. 393
Appendix II Update of the Drug Resistance Mutations in HIV-1: Fall 2006p. 417
Indexp. 429